{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:26:15Z","timestamp":1792887975679,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.cllc.2016.03.001","type":"journal-article","created":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T03:02:35Z","timestamp":1458183755000},"page":"391-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Characteristics and Clinical Outcomes of Sarcomatoid Carcinoma of the Lung"],"prefix":"10.1016","volume":"17","author":[{"given":"Mony","family":"Ung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Rouquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Filleron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3144-5419","authenticated-orcid":false,"given":"Kristell","family":"Taillandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Brouchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaafar","family":"Bennouna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Delord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Milia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Mazi\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2016.03.001_bib1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1183\/09031936.01.00275301","article-title":"The new World Health Organization classification of lung tumours","volume":"18","author":"Brambilla","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cllc.2016.03.001_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.surg.2012.05.007","article-title":"Outcomes of sarcomatoid carcinoma of the lung: a surveillance, epidemiology, and end results database analysis","volume":"152","author":"Yendamuri","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.cllc.2016.03.001_bib3","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/JTO.0b013e31812f3c1a","article-title":"The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours","volume":"2","author":"Goldstraw","year":"2007","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2016.03.001_bib4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cllc.2016.03.001_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00000478-200303000-00004","article-title":"Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases","volume":"27","author":"Rossi","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cllc.2016.03.001_bib6","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/00000478-200309000-00003","article-title":"Pleomorphic carcinomas of the lung show a selective distribution of gene products involved in cell differentiation, cell cycle control, tumor growth, and tumor cell motility: a clinicopathologic and immunohistochemical study of 31 cases","volume":"27","author":"Pelosi","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cllc.2016.03.001_bib7","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1097\/PAS.0b013e3181804302","article-title":"Pleomorphic carcinoma of the lung: clinicopathologic characteristics of 70 cases","volume":"32","author":"Mochizuki","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cllc.2016.03.001_bib8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jtcvs.2007.04.018","article-title":"Pleomorphic carcinoma of the lung: a surgical outcome","volume":"134","author":"Yuki","year":"2007","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cllc.2016.03.001_bib9","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/1097-0142(19940615)73:12<2936::AID-CNCR2820731210>3.0.CO;2-U","article-title":"Pleomorphic (spindle\/giant cell) carcinoma of the lung: a clinicopathologic correlation of 78 cases","volume":"73","author":"Fishback","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2016.03.001_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1066896908330049","article-title":"Review article: pulmonary sarcomatoid carcinomas: a practical overview","volume":"18","author":"Pelosi","year":"2010","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.cllc.2016.03.001_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5858\/2008-0547-RAR.1","article-title":"Sarcomatoid carcinoma of the lung: histologic criteria and common lesions in the differential diagnosis","volume":"134","author":"Franks","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cllc.2016.03.001_bib12","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.athoracsur.2007.03.099","article-title":"Sarcomatoid carcinoma of the lung: a predictor of poor prognosis","volume":"84","author":"Martin","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2016.03.001_bib13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000333095","article-title":"Clinicopathologic outcomes of curative resection for sarcomatoid carcinoma of the lung","volume":"81","author":"Park","year":"2011","journal-title":"Oncology"},{"key":"10.1016\/j.cllc.2016.03.001_bib14","first-page":"3331","article-title":"Tumor angiogenesis in 75 cases of pleomorphic carcinoma of the lung","volume":"32","author":"Tsubata","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cllc.2016.03.001_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.lungcan.2007.05.006","article-title":"Palliative chemotherapy for pulmonary pleomorphic carcinoma","volume":"58","author":"Bae","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2016.03.001_bib16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12032-008-9117-4","article-title":"The role of palliative chemotherapy for advanced pulmonary pleomorphic carcinoma","volume":"26","author":"Hong","year":"2009","journal-title":"Med Oncol"},{"key":"10.1016\/j.cllc.2016.03.001_bib17","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1097\/01.JTO.0000437008.00554.90","article-title":"Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma","volume":"8","author":"Vieira","year":"2013","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2016.03.001_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(16)00004-0","article-title":"Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)","author":"Barlesi","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cllc.2016.03.001_bib19","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1002\/ijc.24610","article-title":"EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: implications for anti-EGFR treatment of a rare lung malignancy","volume":"125","author":"Italiano","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cllc.2016.03.001_bib20","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/JTO.0b013e3181ce3e3c","article-title":"Pulmonary pleomorphic carcinoma: a clinicopathological study including EGFR mutation analysis","volume":"5","author":"Kaira","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2016.03.001_bib21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.lungcan.2009.06.002","article-title":"Clinical characteristics of pleomorphic carcinoma of the lung","volume":"68","author":"Ito","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2016.03.001_bib22","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1245\/s10434-011-1621-7","article-title":"EGFR and p53 status of pulmonary pleomorphic carcinoma: implications for EGFR tyrosine kinase inhibitors therapy of an aggressive lung malignancy","volume":"18","author":"Chang","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.cllc.2016.03.001_bib23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/JTO.0b013e318241655f","article-title":"c-MET\/phospho-MET protein expression and MET gene copy number in non-small cell lung carcinomas","volume":"7","author":"Tsuta","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2016.03.001_bib24","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1200\/JCO.2008.19.1635","article-title":"Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients","volume":"27","author":"Cappuzzo","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2016.03.001_bib25","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1200\/JCO.2015.62.0674","article-title":"Next-generation sequencing of pulmonary sarcomatoid carcinoma reveals high frequency of actionable MET gene mutations","volume":"34","author":"Liu","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2016.03.001_bib26","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1093\/annonc\/mdv232","article-title":"High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta panel: exploring therapeutic targets","volume":"26","author":"Fallet","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2016.03.001_bib27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.lungcan.2015.10.028","article-title":"Responses to the multitargeted MET\/ALK\/ROS1 inhibitor crizotinib and co-occurring mutations in lung adenocarcinomas with MET amplification or MET exon 14 skipping mutation","volume":"90","author":"Jorge","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2016.03.001_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2016.03.001_bib29","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the treatment of non-small-cell lung cancer","volume":"372","author":"Garon","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2016.03.001_bib30","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2016.03.001_bib31","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/JTO.0b013e318292be18","article-title":"Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1)","volume":"8","author":"Velcheti","year":"2013","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2016.03.001_bib32","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1016\/j.ejca.2015.08.013","article-title":"Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: comparison of sarcomatous and carcinomatous areas","volume":"51","author":"Kim","year":"2015","journal-title":"Eur J Cancer"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730416300304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730416300304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:05:47Z","timestamp":1761505547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730416300304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1525730416300304"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2016.03.001","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and Clinical Outcomes of Sarcomatoid Carcinoma of the Lung","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2016.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}